Daylight Savings Time can disrupt the environment and daily routine of people with Alzheimer’s. See how to be proactive when changing the clock.
A groundbreaking study corrected the circadian disruptions seen in Alzheimer’s mice by using time-restricted feeding. This may improve sleep, sundowning, confusion and memory.
Environment, Empathy and Engagement improve sundowning, or sundowners syndrome, in dementia and Alzheimer’s. Explore effective strategies to comfort and support your loved ones symptoms.
In “SUNDOWNING SYNDROME,” people with dementia show high levels of anxiety, agitation, overactivity and delirium. It typically occurs in late afternoon and evening, before their normal time to go to bed. Learn how brain biology explains “sundowning.”
VIDEO ON SUNDOWNING: See UCLA’s Dementia Care Program deal with end-of-day agitation and irritability, known as “Sundowning”. A caregiver asks, “My loved one’s behavior tends to get worse when the sun starts to go down. He appears exhausted and restless. What can I do to get him through this time of the day?”
Alzheimer’s research from UVA Health suggests that enhanced light sensitivity may contribute to “sundowning” – the worsening of symptoms late in the day.
For 12 years, a special program called “Dusk ‘Til Dawn” has been successfully fighting sundowning.
The US Food and Drug Administration has announced the supplemental approval of Rexulti (brexpiprazole) oral tablets for the treatment of agitation associated with dementia due to Alzheimer’s. Learn more.
The FDA has approved the supplemental New Drug Application (sNDA) of REXULTI® (brexpiprazole) for the treatment of agitation associated with Alzheimer’s. It’s the first such treatment to be approved in the US. Learn more.
“Sundowning” describes agitation and anxiety often felt towards the end of the day in dementia. See what it is and what you can do about it.
Stanford Medicine’s new analysis of a vaccination program found shingles vaccines appear to lower dementia diagnoses by 20% — more than any other known intervention.
Tau and amyloid are the two culprits behind Alzheimer’s. Biogen gave the world Leqembi to treat amyloid. Now, learn how Biogen’s Investigational Tau-Targeting Therapy BIIB080 just received FDA Fast Track Designation.
Interestingly, loving care does not require twice the time. But it does require twice the presence.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. It has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor